Arable Group of Companies

Arable Medical Centers represents the next generation in personalized healthcare offering the newest advances in biomedicine, therapeutics and diagnostics. By combining conventional medicine with ongoing innovations in biotechnology, physical medicine, pharmacology, and alternative therapies. These methods include early diagnosis, treatment, and promoting rapid recovery from disease, injury, immunorepression, and hormonal imbalance through access to advanced non-invasive (or minimally-invasive) biomedical technology. To gain access to such diverse technology, Arable Medical Centers collaborates with major research facilities and universities including UCLA Ronald-Reagan Research, the University of Illinois at Urbana-Champaign (UIUC), and Harvard Medical Center. Of the aforementioned available technologies, our initial strategic focus concentrates on deploying AraLight LED therapy throughout the UAE and the greater Middle East, followed by expansion into North Africa and India. Arable also facilitates clinical trials on behalf of its partners. Headquartered in Dubai, Arable Medical Centers operates throughout the UAE with a polyclinic license from the MOH. Our services are available in Arable Medical Centers in Business Bay and the Barsha/Marina districts (opening soon), as well as within major hospitals in Dubai and Sharjah, with more to come. A total of 10 centers are planned within the UAE alone. Aside from its medical center facilities, our personalized approach to medicine includes physician house calls, regular in-home care and treatments, plus cloud-connected personal biometrics (e-Checkup™) and therapies (e-Prescription™). We employ new and emerging biotechnology to make personalized health care affordable, and to proactively concentrate on keeping people healthy rather than waiting till they fall ill.